Cprx stock price target

Real time Catalyst Pharmaceuticals (CPRX) stock price quote, stock graph, news & analysis. Real time Catalyst Pharmaceuticals (CPRX) stock price quote, stock graph, news & analysis. CPRX | Stock Snapshot - Fidelity

Despite Unexpected Competition From Jacobus, Catalyst ... May 20, 2019 · Despite concerns over Firdapse's $375,000 price tag, insurers are generally willing to reimburse and Catalyst itself provides copay assistance to ensure that all … CATALYST PHARMACEUTICALS, INC. : CPRX Stock Price ... Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with rare debilitating diseases. Catalyst Pharmaceuticals Inc : CPRX Stock Price Quote at ... Free current stock price quotes and data for Catalyst Pharmaceuticals Inc (CPRX). Research news, charts, stock market performance and earnings. Quotes Snapshot > CPRX. Catalyst Pharmaceuticals Inc CPRX:NASDAQ. Set Alert Options Streaming Charts. Last Price $3.86 Cboe Real-Time Cantor Fitzgerald Lifts Price Target on Catalyst Pharmaceuticals

Feb 05, 2020 · Institutional Ownership Percentage: 8/19/19- 60.98% 8/14/19 - 60.15% Shares Purchased this month by Institutions: 19 Million . Q2-19 Financial Results. Product revenue, net in the second quarter 2019 was $28.8 million

Online Stock Comparison - Compare Catalyst Pharmaceuticals, Inc. (CPRX) to four other stocks with NASDAQ.com's stock comparison tool. Despite Unexpected Competition From Jacobus, Catalyst ... May 20, 2019 · Despite concerns over Firdapse's $375,000 price tag, insurers are generally willing to reimburse and Catalyst itself provides copay assistance to ensure that all … CATALYST PHARMACEUTICALS, INC. : CPRX Stock Price ... Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with rare debilitating diseases. Catalyst Pharmaceuticals Inc : CPRX Stock Price Quote at ...

1 Jan 2020 stocks heading into 2020. Here's a look at several stocks analysts recommend. Catalyst Pharmaceuticals Inc (CPRX). Like Vivint, biotech 

CPRX - Research and Analysis for CATALYST … In-depth view of key statistics and finances for CATALYST PHARMACEUTICALS, INC. (CPRX) on MSN Money. Why Momentum Investors Should Watch Catalyst ... CPRX Stock Insider Trading. Reports are indicating that there were more than several insider trading activities at Catalyst Pharmaceuticals, Inc. (CPRX), starting from INGENITO GARY, who sold 150,000 shares at the price of $4.82 back on Dec 05. Ride Out The Next Market Storm With Catalyst ... Mar 09, 2020 · The stock was given Neutral rating by Piper Jaffray in its report released on April 26, 2016, the day when the price target on the stock was placed at 1. ROTH Capital was of a view that CPRX is Buy in its latest report on September 30, 2014. ROTH Capital thinks that CPRX is worth Buy rating. CPRX: Catalyst Pharmaceuticals, Inc. - Price & EPS ...

13 Mar 2020 The shares of Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) has been Amongst the analysts that rated the stock, 0 have recommended 

Get today's Catalyst Pharmaceuticals Inc stock price and latest CPRX news as well as Catalyst Pharmaceuticals real-time stock quotes, technical analysis, full  11 Mar 2020 One of the reasons why Healthcare stocks may go bullish is to be a solid investment option, with Wall Street analysts expecting its price to  Prev Close 3.92, 52 Wk Low 2.23. Open 4.00, 52 Wk High 7.67. Day Low 3.83, Volume 1.0M. Day High 4.12, Avg 10D Vol 2.1M 

Catalyst Pharmaceuticals Stock Price Forecast, CPRX stock price prediction. The best long-term & short-term Catalyst Pharmaceuticals share price prognosis for 

Checking the True Picture for Catalyst Pharmaceuticals ...

Nov 08, 2019 · 4 Wall Street analysts have issued ratings and price targets for Catalyst Pharmaceuticals in the last 12 months. Their average twelve-month price target is $9.75, suggesting that the stock has a possible upside of 151.29%. The high price target for CPRX is … Catalyst Pharmaceuticals, Inc. (CPRX) Stock Price, Quote ... Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. CPRX | Catalyst Pharmaceuticals Inc. Analyst Estimates ... Nov 10, 2019 · Catalyst Pharmaceuticals Inc. analyst estimates by MarketWatch. View CPRX revenue estimates and earnings estimates, as well as analyst recommendations. CPRX | Catalyst Pharmaceuticals Inc. Analyst Estimates ... Catalyst Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CPRX updated stock price target summary.